Browse / ARA-290
Cibinetide · EPO-receptor innate-repair peptide
ARA-290 (cibinetide) is an 11-residue peptide derived from the helix-B structure of erythropoietin, designed to engage the innate repair receptor without stimulating erythropoiesis. All catalog material is for laboratory research use only.
Non-hematopoietic EPO analogue, Innate repair receptor, Neuropathy trial history
Selective IRR (EPOR/CD131) signaling is studied for small-fiber neuropathy and inflammatory models. It is an investigational molecule, not a red-cell growth factor.
Cibinetide (EPO-derived helix B mimetic); primary structure on certificate.
Short peptide; trial schedules are not catalog instructions.
Age verification
The products on this website are only for research professionals of 21+ years of age, purchasing for research purposes only. Any human or animal consumption is strictly prohibited.
Research Use Only — not for human or animal consumption.
You must be at least 21 years old to enter this website. Please leave and return when you meet the age requirement.